Menu
- report storage
- solutions
- Why our reports
- perceptionskeyboard_down_arrow
press release
business ideas
knowledge series
Pharmaceutical Vision
Lymphedema Treatment Market by Indication (Primary and Secondary Lymphedema), Treatment Type (Compression Therapy, Drug Therapy), End User (Hospitals, Specialty Clinics) Global Outlook and Forecast 2022-2030
GR-749763 Category: Pharmaceutical Products
Number of pages: 100 | Report format: PDF | Release date: February 20, 2023
Historical Years â 2020 | Base year â 2021 | Forecast years 2022-2030
Scope of the Lymphedema Treatment Market
report attribute | details |
Market size value in 2021 | $780 million |
Income forecast 2030 | $1,572 million |
growth rate | 8.1% TACC from 2022 to 2030 |
Base year for estimate | 2021 |
forecast period | 2022-2030 |
historical year | 2020 |
segments covered | Indication, type of treatment, end user and region |
Alcance regional | North America, Europe, Asia Pacific and Rest of the World (ROW) |
Report Overview
According to the in-depth market valuation study conducted by Growth Plus Reports, the global Lymphedema Treatment market was valued at US$780 million in 2021 and is expected to register a CAGR of 8.1% in revenue by 2030 to reach $1572 million.
Market Basics
The global lymphedema treatment market is expected to grow significantly in the coming years due to the increasing prevalence of the condition, advances in treatment options, increasing awareness and understanding of the condition, and the availability of a wide range of products and services for the treatment will grow of lymphedema. . The market is driven by an aging population, higher cancer incidence and an increase in surgical procedures, all of which can increase the risk of lymphedema. Compression stockings are the most commonly used products to treat lymphedema. But other products such as pumps and bandages are also important. Surgical procedures and new therapies such as stem cell and gene therapy are expected to contribute to the market growth. The market is highly fragmented, with many players offering a range of products and services.
The global lymphedema treatment market is expected to witness continued growth in the coming years, driven by rising prevalence, advancements in treatment options, patient-centric care and the availability of a wide range of lymphedema products and services.
Lymphedema is a chronic condition that results from the accumulation of lymphatic fluid in tissues, causing swelling of the affected part of the body. Treatment of lymphedema may involve a combination of approaches such as compression therapy, manual lymphatic drainage, exercise, skin care, and surgery. The goal of treating lymphedema is to improve the flow of lymphatic fluid, reduce swelling, and prevent infection and other complications associated with the disease. Treatment can be tailored to the individual needs of each patient. It may involve continuous monitoring to manage the symptoms of the condition.
[5675654]
Market dynamics
The incidence of lymphedema is increasing worldwide due to the aging of the population, the rise in cancer and the increase in surgical procedures. Significant advances have been made in the development of new compression garments, surgical procedures and new therapies such as gene therapy and stem cell therapy. These new treatment options are designed to improve patient outcomes and expand the range of options available to patients. Governments around the world are taking initiatives to raise awareness of lymphedema and offer patients better treatment options. For example, in the US, the Lymphedema Treatment Act of 2022 was introduced to increase access to treatment for lymphedema patients, driving growth in the US lymphedema treatment market.
Additionally, the increasing availability of lymphedema products and accessories is expected to contribute to the growth of the market. As healthcare spending continues to rise around the world, patients may have access to better treatment options for lymphedema. This is expected to fuel the growth of the Lymphedema Treatment market in the coming years. However, the high cost associated with treating lymphedema, particularly for patients requiring ongoing therapy or surgical intervention, is the greatest limiting factor in the management of lymphedema worldwide.Market. Additionally, some countries have no or limited reimbursement policies for lymphedema treatment, which also hampers the growth of lymphedema treatment.Mercado.
market ecosystem
Worldwide treatment of edemaThe market is analyzed from three perspectives: indication, treatment type, end user and region.
Lymphedema Treatment Market By Indication
[7457546]
According to the indications, the global treatment of edemaThe market is segmented into Primary Lymphedema and Secondary Lymphedema.
The secondary lymphedema segment dominates lymphedema treatmentMarket with the highest revenue share in 2021. Secondary lymphedema has a higher incidence rate than primary lymphedema because it can occur in people of all ages and can be caused by many factors. This results in a larger number of patients requiring treatment, driving growth in this segment. Awareness of the risk of developing lymphedema after cancer surgery has increased, meaning patients are more likely to seek treatment for secondary lymphedema. In addition, other treatment options for secondary lymphedema are available, including compression therapy, manual lymphatic drainage and surgical procedures, which are driving the growth of the segment. In some countries, reimbursement policies may cover secondary lymphedema treatment, making it more affordable for patients. This could further increase the demand for treatment options for lymphedema.
Lymphedema Treatment Market by Treatment Type
Depending on the type of treatment, the general treatment of edemaThe market is segmented into compression therapy, drug therapy, laser therapy, and others.
The compression therapy segment accounted for the majority of its lymphedema treatment revenuemarket in 2021. Compression therapy has been shown to effectively reduce swelling and improve lymphatic flow in patients with lymphedema. It is often recommended as a first-line treatment for lymphedema and is considered the standard of care for the condition, increasing the demand for compression therapy in the management of lymphedema. Compression therapy is a non-invasive treatment that does not require surgery or medication. This makes it an attractive option for patients who prefer non-invasive treatments or who cannot undergo surgery. Compression therapy is relatively inexpensive compared to other lymphedema treatments such as surgery or manual lymphatic drainage. It's also a long-term care option, and compression garments can be reused and washed multiple times, fueling growth in this segment.
End User Lymphedema Treatment Market
On the basis of end-user, the global Lymphedema Treatment market is segmented into Hospitals, Specialty Clinics, Ambulatory Surgical Centers, and Others.
The hospital segment accounted for a significant revenue share of the lymphedema treatment market in 2021. Hospitals typically have specialized departments and healthcare professionals trained to manage lymphedema, such as surgeons, physical therapists, and occupational therapists. This makes hospitals the preferred choice for patients who want advanced care and treatment for lymphedema. Hospitals have access to a broader range of lymphedema treatment options, including advanced surgical procedures, medical devices and therapeutic interventions, driving segment growth. Hospitals can perform a wide range of diagnostic tests and imaging to diagnose and evaluate lymphedema. This can help develop an effective treatment plan for the patient and thereby increase segment growth.
Lymphedema Treatment Market by Regions
Geographically, the global Lymphedema Treatment market has been segmented into North America, Europe, Asia Pacific and Rest of the World.
North America dominated the global Lymphedema Treatment market in 2021. North America has a relatively high prevalence of lymphedema, driving demand for treatment options. According to the National Center for Biotechnology Information, primary lymphedema affects about 1 in 100,000 people and secondary lymphedema affects about 1 in 1,000 people in the US with compression devices, lymph vein anastomoses (LVA), and liposuction. North America is home to some of the most advanced medical technologies in the world, including medical devices and surgical procedures that can be used to treat lymphedema. This has stimulated the development of innovative treatment options for lymphedema. Additionally, awareness of lymphedema is growing in North America, which has led to increased patient education and more effective diagnosis and treatment, fueling regional market growth. The elderly population of North America is at increased risk of developing lymphedema as age-related changes in the lymphatic system can increase the likelihood of developing the disease, hence there is an increased demand for lymphedema treatments in North America.
competitive scenario
The Major Listed Vendors for Global Lymphedema Treatment Market are:
- Bio Compression Systems Inc.
- AIROS Medical Inc.
- Touch Systems Technology Inc.
- Smith and Nephew plc
- BSN Medical GmbH
- Cardinal Health Inc.
- Lohmann & Rauscher GmbH & Co. KG
- Empresa 3M
- Wright-Therapieprodukte
- Mego Afek Ltda.
- Herantis Pharma Plc
- SIGVARIS GROUP
Strategic Developments
- In October 2022, ImpediMed Limited signed a global strategic business partnership and pilot program with GenesisCare. The SOZO devices will be the first five to be rolled out as part of the pilot program, which aims to develop lymphedema screening services for breast cancer patients in facilities across the country.
- In April 2022, Koya Medical announced the commercial availability of its Dayspring active compression system for the treatment of lymphedema and venous disease in the lower extremities in the United States. Dayspring is the first FDA-approved non-pneumatic active dynamic compression treatment. Specially designed for patient mobility, it is portable.
Frequently asked questions about this report
Geographically, North America has the highest revenue share of the market, followed by Europe; and Asia Pacific is the fastest growing regional market for lymphedema treatment.
Lymphedema treatment refers to the different interventions and approaches used to control and relieve the symptoms of lymphedema. This chronic condition is the result of the accumulation of lymphatic fluid in the tissues, which causes inflammation in the affected part of the body.
Bio Compression Systems Inc., AIROS Medical Inc., Tactile Systems Technology Inc., Smith & Nephew plc, BSN medical GmbH and Cardinal Health Inc. are some of the leading companies operating in the global lymphedema treatment market.
The compression therapy segment has the largest share of the market for the treatment of lymphedema.
The market for the treatment of lymphedema is estimated at US$1.572 billion by 2030.
Index
- INTRODUCTION
- market ecosystem
- timeline under consideration
- Historical years â 2020
- Base year â 2021
- Forecast years 2022 to 2030
- Currency used in the report
- RESEARCH METHODOLOGY
- research focus
- Data collection methodology
- data sources
- secondary sources
- primary sources
- Approach to Market Estimation
- Prost
- Film
- Market Forecast Model
- Limitations and Assumptions
- PREMIUM INFORMATION
- Current market trends (COVID-19 perspective)
- Key Players and Competitive Positioning (2021)
- MARKET DYNAMIC
- driver
- Limitations/Challenges
- occasions
- ANALYSIS AND FORECAST OF THE WORLDWIDE MARKET FOR THE TREATMENT OF LYMPHODA BY INDICATION
- primary lymphedema
- Secondary Lymphedema
- ANALYSIS AND FORECAST OF THE GLOBAL LYMPHODA TREATMENT MARKET BY TREATMENT TYPE
- compression therapy
- drug therapy
- laser therapy
- Others
- ANALYSIS AND FORECAST OF GLOBAL LYMPHODA TREATMENT MARKET BY CONSUMER
- hospitals
- Specialized clinics
- Ambulatory Surgical Centers
- Others
- WORLDWIDE LYMPHEDEMA TREATMENT MARKET: ANALYSIS AND FORECAST BY REGION
- Lymphedema Treatment Market in North America
- North America Lymphedema Treatment Market By Indication
- North America Lymphedema Treatment Market by Type of Treatment
- North America Lymphedema Treatment Market by End-User
- North America Lymphedema Treatment Market by Country
- US.
- US Lymphedema Treatment Market by Indication
- US Lymphedema Treatment Market, by Treatment Type
- US Lymphedema Treatment Market by End User
- You have
- Canadian Lymphedema Treatment Market by Indication
- Canada Lymphedema Treatment Market by Type of Treatment
- Canada Lymphedema Treatment Market by End-User
- US.
- European market for the treatment of lymphedema
- European Lymphedema Treatment Market by Indication
- Europe Lymphedema Treatment Market, by Type of Treatment
- European Lymphedema Treatment Market by End-User
- European Lymphedema Treatment Market by Country/Region
- Deutschland
- Lymphedema Treatment Market in Germany by Indication
- Germany Lymphedema Treatment Market by Treatment Type
- German Lymphedema Treatment Market by End User
- GREAT BRITAIN.
- UK Lymphedema Treatment Market by Indication
- UK Lymphedema Treatment Market by Type of Treatment
- UK Lymphedema Treatment Market by End-User
- France
- France Lymphedema Treatment Market by Indication
- France Lymphedema Treatment Market by Treatment Type
- France Lymphedema Treatment Market by End-User
- Spain
- Spain Lymphedema Treatment Market by Indication
- Lymphedema Treatment Market in Spain by Treatment Type
- Spain Lymphedema Treatment Market by End-User
- Italy
- Lymphedema Treatment Market in Italy by Indication
- Lymphedema Treatment Market in Italy by Treatment Type
- Lymphedema Treatment Market in Italy by End-User
- rest of Europe
- Rest of Europe Lymphedema Treatment Market by Indication
- Rest of Europe Lymphedema Treatment Market by Treatment Type
- Rest of Europe Lymphedema Treatment Market by End User
- Deutschland
- Asia Pacific Lymphedema Treatment Market
- Asia Pacific Lymphedema Treatment Market By Indication
- Asia Pacific Lymphedema Treatment Market by Treatment Type
- Asia Pacific Lymphedema Treatment Market by End-User
- Asia Pacific Lymphedema Treatment Market by Country/Region
- porcelain
- China Lymphedema Treatment Market by Indication
- Lymphedema Treatment Market in China by Treatment Type
- China's Lymphedema Treatment Market by End-User
- Japan
- Japan Lymphedema Treatment Market by Indication
- Japan Lymphedema Treatment Market by Treatment Type
- Japan Lymphedema Treatment Market by End User
- If
- Lymphedema Treatment Market in India by Indication
- Lymphedema Treatment Market in India by Treatment Type
- Indian Lymphedema Treatment Market by End-User
- South Korea
- South Korea Lymphedema Treatment Market by Indication
- South Korea Lymphedema Treatment Market by Treatment Type
- South Korea's Lymphedema Treatment Market by End-User
- Australia
- Australian Lymphedema Treatment Market By Indication
- Australia Lymphedema Treatment Market by Type of Treatment
- Australia Lymphedema Treatment Market by End-User
- Rest of Asia Pacific
- Rest of Asia Pacific Lymphedema Treatment Market by Indication
- Rest of Asia Pacific Lymphedema Treatment Market by Treatment Type
- Rest of Asia-Pacific Lymphedema Treatment Market by End-User
- porcelain
- Rest of the Global Lymphedema Treatment Market
- Rest of Global Lymphedema Treatment Market by Indication
- Rest of Global Lymphedema Treatment Market by Type of Treatment
- Rest of Global Lymphedema Treatment Market by End-User
- Rest of Global Lymphedema Treatment Market by Regions
- Latin America
- Latin American Lymphedema Treatment Market by Indication
- Latin America Lymphedema Treatment Market by Type of Treatment
- Global Latin American Lymphedema Treatment Market by End-User
- Middle East and Africa
- Middle East and Africa Lymphedema Treatment Market by Indication
- Middle East and Africa Lymphedema Treatment Market by Treatment Type
- Middle East and Africa Lymphedema Treatment Market by End-User
- Latin America
- Lymphedema Treatment Market in North America
- COMPANY PROFILES
- Bio Compression Systems Inc.
- business snapshot
- products offered
- Financial Details*
- strategic development
- AIROS Medical Inc.
- Touch Systems Technology Inc.
- Smith and Nephew plc
- BSN Medical GmbH
- Cardinal Health Inc.
- Lohmann & Rauscher GmbH & Co. KG
- Empresa 3M
- Wright-Therapieprodukte
- Mego Afek Ltda.
- Herantis Pharma Plc
- SIGVARIS GROUP
- Bio Compression Systems Inc.
*Financial performance insights are subject to availability of information in the public domain
table list
- Global Lymphedema Treatment Market by Indication, 2020-2030 (Million US$)
- Global Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million US$)
- Global Lymphedema Treatment Market, by End-User, 2020-2030 (Million US$)
- Global Lymphedema Treatment Market, By Region, 2020-2030 (Million US$)
- North America Lymphedema Treatment Market by Indication, 2020-2030 (Million USD)
- North America Lymphedema Treatment Market, by Treatment Type, 2020-2030 (US$ Mn)
- North America Lymphedema Treatment Market, by End User, 2020-2030 (Million USD)
- North America Lymphedema Treatment Market, by Country, 2020-2030 (Million USD)
- US Lymphedema Treatment Market, by Indication, 2020-2030 (USD Mn)
- US Lymphedema Treatment Market, by Treatment Type, 2020-2030 (US$ Mn)
- US Lymphedema Treatment Market, by End-User, 2020-2030 (Million USD)
- Canada Lymphedema Treatment Market, By Indication, 2020-2030 (Million USD)
- Canada Lymphedema Treatment Market, by Treatment Type, 2020-2030 (US$ Mn)
- Canada Lymphedema Treatment Market, by End-User, 2020-2030 (Million US$)
- European Lymphedema Treatment Market by Indication, 2020-2030 (Million USD)
- European Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million USD)
- Europe Lymphedema Treatment Market, by End User, 2020-2030 (Million US$)
- European Lymphedema Treatment Market, by Country/Region, 2020-2030 (Million US$)
- German Lymphedema Treatment Market, By Indication, 2020-2030 (USD Mn)
- Germany Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million USD)
- Germany Lymphedema Treatment Market, by End-User, 2020-2030 (Million USD)
- UK Lymphedema Treatment Market, by Indication, 2020-2030 (USD Mn)
- UK Lymphedema Treatment Market, by Treatment Type, 2020-2030 (USD Mn)
- UK Lymphedema Treatment Market, by End User, 2020-2030 (USD Mn)
- France Lymphedema Treatment Market by Indication, 2020-2030 (Million USD)
- France Lymphedema Treatment Market, by Type of Treatment, 2020-2030 (Million USD)
- France Lymphedema Treatment Market, by End-User, 2020-2030 (Million USD)
- Lymphedema Treatment Market in Italy, by Indication, 2020-2030 (Million USD)
- Lymphedema Treatment Market in Italy, by Type of Treatment, 2020-2030 (Million USD)
- Italy Lymphedema Treatment Market, by End-User, 2020-2030 (Million US$)
- Lymphedema Treatment Market in Spain, by Indication, 2020-2030 (Million US$)
- Lymphedema Treatment Market in Spain, by Type of Treatment, 2020-2030 (Million US$)
- Lymphedema Treatment Market in Spain, by End User, 2020-2030 (Million US$)
- Rest of Europe Lymphedema Treatment Market, By Indication, 2020-2030 (Million USD)
- Rest of Europe Lymphedema Treatment Market, by Treatment Type, 2020-2030 (US$ Mn)
- Rest of Europe Lymphedema Treatment Market by End-User, 2020-2030 (Million USD)
- Asia Pacific Lymphedema Treatment Market By Indication, 2020-2030 (Million USD)
- Asia Pacific Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million USD)
- Asia Pacific Lymphedema Treatment Market, by End-User, 2020-2030 (Million US$)
- Asia Pacific Lymphedema Treatment Market, By Country/Region, 2020-2030 (Million US$)
- China Lymphedema Treatment Market, By Indication, 2020-2030 (US$ Million)
- China Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million US$)
- China Lymphedema Treatment Market, by End-User, 2020-2030 (Million US$)
- Japan Lymphedema Treatment Market, By Indication, 2020-2030 (Million USD)
- Japan Lymphedema Treatment Market, by Treatment Type, 2020-2030 (US$ Million)
- Japan Lymphedema Treatment Market, by End-User, 2020-2030 (US$ Million)
- Indian Lymphedema Treatment Market, By Indication, 2020-2030 (Million US$)
- Indian Lymphedema Treatment Market, by Treatment Type, 2020-2030 (US$ Mn)
- Indian Lymphedema Treatment Market, by End User, 2020-2030 (Million US$)
- South Korea Lymphedema Treatment Market, by Indication, 2020-2030 (US$ Mn)
- South Korea Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million US$)
- South Korea Lymphedema Treatment Market, by End-User, 2020-2030 (Million US$)
- Australia Lymphedema Treatment Market, By Indication, 2020-2030 (USD Mn)
- Australia Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million USD)
- Australia Lymphedema Treatment Market, by End-User, 2020-2030 (Million USD)
- Rest of Asia-Pacific Lymphedema Treatment Market, by Indication, 2020-2030 (USD Mn)
- Rest of Asia-Pacific Lymphedema Treatment Market, by Treatment Type, 2020-2030 (US$ Mn)
- Rest of Asia-Pacific Lymphedema Treatment Market, by End-User, 2020-2030 (USD Mn)
- Rest of Global Lymphedema Treatment Market, By Indication, 2020-2030 (Million USD)
- Rest of Global Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million USD)
- Rest of Global Lymphedema Treatment Market by End User, 2020–2030 (Million US$)
- Rest of Global Lymphedema Treatment Market by Region, 2020-2030 (Million USD)
- Latin America Lymphedema Treatment Market by Indication, 2020-2030 (Million USD)
- Latin America Lymphedema Treatment Market, by Type of Treatment, 2020-2030 (Million US$)
- Latin America Lymphedema Treatment Market, by End-User, 2020-2030 (Million US$)
- Middle East and Africa Lymphedema Treatment Market by Indication, 2020-2030 (Million USD)
- Middle East and Africa Lymphedema Treatment Market, by Treatment Type, 2020-2030 (Million USD)
- Middle East and Africa Lymphedema Treatment Market, by End-User, 2020-2030 (Million USD)
List of Figures
- Lymphedema Treatment Market Ecosystem
- Global Overview of Lymphedema Treatment Market, 2020-2030
- Global Lymphedema Treatment Market Overview by Regions, 2020-2030
- Global Lymphedema Treatment Market: Assessing the Impact of the COVID-19 Pandemic
- Global Lymphedema Treatment Market: Key Players and Competitive Positioning (2021)
- Lymphedema treatment: market dynamics
- Global Lymphedema Treatment Market for Primary Lymphedema, 2020-2030 (Million US$)
- Global Lymphedema Treatment for Secondary Lymphedema Market, 2020-2030 (Million US$)
- Global Compression Therapy for Lymphedema Treatment Market, 2020-2030 (Million US$)
- Global Pharmacological Therapies for Lymphedema Treatment Market, 2020-2030 (Million US$)
- Global Laser Therapy for Lymphedema Treatment Market, 2020-2030 (Million US$)
- Global Other Treatments for Lymphedema Treatment Market, 2020-2030 (Million US$)
- Global Hospital Lymphedema Treatment Market, 2020-2030 (Million US$)
- Global Lymphedema Treatment Market for Specialty Hospitals, 2020-2030 (Million US$)
- Global Ambulatory Surgical Lymphedema Treatment Market, 2020-2030 (Million US$)
- Global Lymphedema Treatment Market for Others, 2020-2030 (Million US$)
- North America Lymphedema Treatment Market, 2020-2030 (Million USD)
- US Lymphedema Treatment Market, 2020-2030 (USD Mn)
- Canada Lymphedema Treatment Market, 2020-2030 (Million US$)
- European Lymphedema Treatment Market, 2020-2030 (Million USD)
- Germany Lymphedema Treatment Market, 2020-2030 (Million USD)
- UK Lymphedema Treatment Market, 2020-2030 (USD Mn)
- Lymphedema Treatment Market in France, 2020-2030 (Million USD)
- Lymphedema Treatment Market in Italy, 2020-2030 (Million USD)
- Lymphedema Treatment Market in Spain, 2020-2030 (Million US$)
- Rest of Europe Lymphedema Treatment Market, 2020-2030 (Million USD)
- Asia-Pacific Lymphedema Treatment Market, 2020-2030 (Million USD)
- China Lymphedema Treatment Market, 2020-2030 (Million US$)
- Japan Lymphedema Treatment Market, 2020-2030 (US$ Million)
- Indian Lymphedema Treatment Market, 2020-2030 (Million US$)
- South Korea Lymphedema Treatment Market, 2020-2030 (Million US$)
- Australia Lymphedema Treatment Market, 2020-2030 (Million USD)
- Rest of Asia-Pacific Lymphedema Treatment Market, 2020-2030 (Million USD)
- Rest of Global Lymphedema Treatment Market, 2020-2030 (Million USD)
- Latin America Lymphedema Treatment Market, 2020-2030 (Million US$)
- Middle East and Africa Lymphedema Treatment Market, 2020-2030 (Million USD)
- Bio Compression Systems Inc. Revenue 2018-2021 (Million US$)
- AIROS Medical Inc. Revenue 2018-2021 (Million US$)
- Touch Systems Technology Inc. Revenue 2018-2021 (Million US$)
- Smith & Nephew Plc Revenue 2018-2021 (in million dollars)
- Revenue of BSN medical GmbH from 2018-2021 (million US dollars)
- Cardinal Health Inc. Revenue 2018-2021 (Million US$)
- Lohmann & Rauscher GmbH & Co. KG Revenue 2018-2021 (in million US dollars)
- 3M Company Revenue 2018-2021 (in million dollars)
- Wright Therapy Product Revenue 2018-2021 (USD Million)
- Mego Afek Ltd. Revenue 2018-2021 (Million US$)
- Herantis Pharma Plc Revenue 2018-2021 (Million USD)
- Revenue of SIGVARIS GROUP 2018-2021 (in million US dollars)
Growth+Reports can now be customized through GRG Health's leading research capabilities and knowledge services.
GrowthMIX's unique approach and GRG Health's robust research methodology help us provide our clients with unique and meaningful insights and uncover trends that lag behind the standard approach.
request customization Check the discount Find out before you buy
-Talk to the Analyst-
go without Free sample?
Enter your email address and we will send you the sample.